Here at Oncopharm and as a part of our core values through transforming the art of innovation in science into customer-centric real solutions by offering accessible and high-quality branded solutions.
We are delighted to announce the relaunch of the well-known brand Xeloda® in the Egyptian market, after marketing authorization transfer from Roche to Cheplapharm Arzneimittel GmbH, through worldwide acquisition for the product, aiming to help thousands of cancer patients through giving the hope to recovery and to live.
